Literature DB >> 22079896

Sugar inhibits the production of the toxins that trigger clostridial gas gangrene.

M B Méndez1, A Goñi, W Ramirez, R R Grau.   

Abstract

Histotoxic strains of Clostridium perfringens cause human gas gangrene, a devastating infection during which potent tissue-degrading toxins are produced and secreted. Although this pathogen only grows in anaerobic-nutrient-rich habitats such as deep wounds, very little is known regarding how nutritional signals influence gas gangrene-related toxin production. We hypothesize that sugars, which have been used throughout history to prevent wound infection, may represent a nutritional signal against gas gangrene development. Here we demonstrate, for the first time, that sugars (sucrose, glucose) inhibited the production of the main protein toxins, PLC (alpha-toxin) and PFO (theta-toxin), responsible for the onset and progression of gas gangrene. Transcription analysis experiments using plc-gusA and pfoA-gusA reporter fusions as well as RT-PCR analysis of mRNA transcripts confirmed that sugar represses plc and pfoA expression. In contrast an isogenic C. perfringens strain that is defective in CcpA, the master transcription factor involved in carbon catabolite response, was completely resistant to the sugar-mediated inhibition of PLC and PFO toxin production. Furthermore, the production of PLC and PFO toxins in the ccpA mutant strain was several-fold higher than the toxin production found in the wild type strain. Therefore, CcpA is the primary or unique regulatory protein responsible for the carbon catabolite (sugar) repression of toxin production of this pathogen. The present results are analyzed in the context of the role of CcpA for the development and aggressiveness of clostridial gas gangrene and the well-known, although poorly understood, anti-infective and wound healing effects of sugars and related substances.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079896     DOI: 10.1016/j.micpath.2011.10.008

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

Review 1.  Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria.

Authors:  Anthony R Richardson; Greg A Somerville; Abraham L Sonenshein
Journal:  Microbiol Spectr       Date:  2015-06

2.  Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity.

Authors:  Jianming Chen; Bruce A McClane
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  NanI Sialidase, CcpA, and CodY Work Together To Regulate Epsilon Toxin Production by Clostridium perfringens Type D Strain CN3718.

Authors:  Jihong Li; John C Freedman; Bruce A McClane
Journal:  J Bacteriol       Date:  2015-08-10       Impact factor: 3.490

4.  A Multi-Serotype Approach Clarifies the Catabolite Control Protein A Regulon in the Major Human Pathogen Group A Streptococcus.

Authors:  Sruti DebRoy; Miguel Saldaña; Dante Travisany; Andrew Montano; Jessica Galloway-Peña; Nicola Horstmann; Hui Yao; Mauricio González; Alejandro Maass; Mauricio Latorre; Samuel A Shelburne
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

5.  Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile.

Authors:  Ana Antunes; Emilie Camiade; Marc Monot; Emmanuelle Courtois; Frédéric Barbut; Natalia V Sernova; Dmitry A Rodionov; Isabelle Martin-Verstraete; Bruno Dupuy
Journal:  Nucleic Acids Res       Date:  2012-09-18       Impact factor: 16.971

6.  A small bioactive glycoside inhibits epsilon toxin and prevents cell death.

Authors:  Abhishek Shivappagowdar; Soumya Pati; Chintam Narayana; Rajagopal Ayana; Himani Kaushik; Raj Sah; Swati Garg; Ashish Khanna; Jyoti Kumari; Lalit Garg; Ram Sagar; Shailja Singh
Journal:  Dis Model Mech       Date:  2019-10-10       Impact factor: 5.758

7.  Genome-wide analysis of in vivo CcpA binding with and without its key co-factor HPr in the major human pathogen group A Streptococcus.

Authors:  Sruti DebRoy; Victor Aliaga-Tobar; Gabriel Galvez; Srishtee Arora; Xiaowen Liang; Nicola Horstmann; Vinicius Maracaja-Coutinho; Mauricio Latorre; Magnus Hook; Anthony R Flores; Samuel A Shelburne
Journal:  Mol Microbiol       Date:  2020-12-29       Impact factor: 3.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.